Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
This innovative medication offers a unique approach that addresses the dual challenges of diabetes and weight simultaneously
Although GLP-1 patches are not currently licensed in the UK, the following guidance applies broadly to transdermal medication systems and would be relevant should such products become available
You can also reach out to your insurance provider to ask about Mounjaro coverage and your out-of-pocket costs
Patients must charge the device daily, and therapy settings are adjusted by the clinical team based on individual response and tolerability
A curve shifted to the right on this scale indicates a greater percentage of patients reporting improvement
You have high baseline BMI where 28.7% weight loss represents a clinically meaningful target
US$ 21.43
US$ 28.81
US$ 23.93
